Nemes Rush Group LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Nemes Rush Group LLC

  • $689 Billion
  • Q3 2024

A detailed history of Nemes Rush Group LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Nemes Rush Group LLC holds 15 shares of XBI stock, worth $1,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$1,384
Previous $1.39 Million 2.3%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023
BUY
$75.38 - $90.23 $1,130 - $1,353
15 New
15 $1.25 Million

Others Institutions Holding XBI

# of Institutions
927
Shares Held
101M
Call Options Held
28.4M
Put Options Held
33.4M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email